Specification

Product Overview

Emjard l tab 5/10mg 14s is a combination medication containing two active ingredients, Empagliflozin and Linagliptin, designed to help manage blood sugar levels in individuals with type 2 diabetes. This prescription medication works by increasing the removal of glucose through the kidneys and reducing the production of glucose in the liver.

Key Benefits

Helps lower blood sugar levels

• Supports weight loss
• Reduces the risk of cardiovascular events
• Improves overall glycemic control
• Convenient once-daily dosing

How It Works

Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones, which stimulate the release of insulin and reduce the production of glucagon.

Storage Instructions

Store Emjard l tab 5/10mg 14s at room temperature away from light and moisture. Keep it out of reach of children and pets. Do not store in the bathroom.

Usage & Safety

Directions for Use

Take Emjard l tab 5/10mg 14s orally as directed by your healthcare provider.

• Swallow the tablet whole with a glass of water.
• It is usually taken once daily with or without food.
• Follow your doctor's instructions carefully for the best results.

Precautions

Precautions

Inform your doctor about any allergies or medical conditions you have before taking this medication.

• Monitor your blood sugar levels regularly as directed by your healthcare provider.
• Avoid alcohol consumption while taking Emjard l tab 5/10mg 14s.
• Be cautious while driving or operating machinery as this medication may cause dizziness.

Additional Information

Manufacturer Information

Emjard l tab 5/10mg 14s is manufactured by Hoechst Pak Ltd, a reputable pharmaceutical company known for producing high-quality medications to improve the health and well-being of patients globally.